J N Frame
Overview
Explore the profile of J N Frame including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vargo J, Snelling B, Ghareeb E, John K, Frame J, Schmidt J, et al.
J Neurooncol
. 2011 Jan;
104(2):595-8.
PMID: 21221711
Malignant gliomas have long been a therapeutic dilemma in neuro-oncology, with a poor overall prognosis. Standard treatment, consisting of primary resection, followed by radiation therapy and temozolomide, has improved prognosis....
2.
Cheson B, Frame J, Vena D, Quashu N, Sorensen J
J Clin Oncol
. 1998 Jul;
16(7):2313-20.
PMID: 9667245
Purpose: To quantify the incidence and severity of tumor lysis syndrome (TLS) as a consequence of fludarabine therapy in patients with advanced chronic lymphocytic leukemia (CLL). Patients And Methods: A...
3.
Shaw G, Falk R, Frame J, Weiffenbach B, Nesbitt J, Pass H, et al.
Cancer Epidemiol Biomarkers Prev
. 1998 Apr;
7(3):215-9.
PMID: 9521436
Previous reports of the association of extensive debrisoquine metabolism, controlled by the cytochrome P450 CYP2D6, with increased lung cancer risk have been conflicting. We examined the hypothesis that genetic polymorphism...
4.
Chute J, Venzon D, Hankins L, Okunieff P, Frame J, Ihde D, et al.
Mayo Clin Proc
. 1997 Nov;
72(10):901-12.
PMID: 9379691
Objective: To determine the outcome of all patients with small-cell lung cancer (SCLC) treated at the US National Cancer Institute between April 1973 and April 1993. Design: We retrospectively analyzed...
5.
Shaw G, Weiffenbach B, Falk R, Frame J, Issaq H, Moir D, et al.
Lung Cancer
. 1997 May;
17(1):61-8.
PMID: 9194027
Previous reports of the association between the debrisoquine polymorphism and lung cancer risk are conflicting. Following the report of an association between lung cancer risk and the variant allele CYP2D6(C),...
6.
Otterson G, Monahan B, Harold N, Steinberg S, Frame J, Kaye F
Am J Med
. 1996 Oct;
101(4):406-12.
PMID: 8873512
Purpose: A common germline mutation in the factor V gene (FV:Q506) has been associated with hypercoagulability in families with heritable predisposition to thrombosis. We examined the prevalence and clinical significance...
7.
Johnson B, Bridges J, Sobczeck M, Gray J, Linnoila R, Gazdar A, et al.
J Clin Oncol
. 1996 Mar;
14(3):806-13.
PMID: 8622028
Purpose: A phase II trial in patients with limited-stage small-cell lung cancer treated with induction etoposide/cisplatin plus twice-daily chest radiotherapy was conducted in an attempt to increase response rates and...
8.
Chute J, Hoffmeister K, Cotelingam J, Davis T, Frame J, Jamieson T
Am J Hematol
. 1996 Mar;
51(3):237-9.
PMID: 8619406
No abstract available.
9.
Laskin W, Knittel D, Frame J
Am J Clin Pathol
. 1995 Jun;
103(6):772-3.
PMID: 7785665
No abstract available.
10.
Shaw G, Falk R, Deslauriers J, Frame J, Nesbitt J, Pass H, et al.
Cancer Epidemiol Biomarkers Prev
. 1995 Jan;
4(1):41-8.
PMID: 7894323
Previous reports of the association between the debrisoquine metabolic polymorphism and lung cancer risk have been conflicting. We examined the hypothesis that the genetically determined ability to metabolize debrisoquine identifies...